Sittner & Nelson »

Halozyme Therapeutics shares owned by Sittner & Nelson

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Sittner & Nelson from 13F filings

Historical chart of Sittner & Nelson investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Sittner & Nelson consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Sittner & Nelson

Quarter filed Position value Share count Share price at filing
2026-03-31 $94k 1.4k 64.63

More positions owned by Sittner & Nelson

Apple (AAPL)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
NVIDIA Corporation (NVDA)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl C (GOOG)
Costco Wholesale Corporation (COST)
Alphabet Cap Stk Cl A (GOOGL)
Chevron Corporation (CVX)
Pimco Etf Tr Muni Income Opp (MINO)
T Rowe Price Etf Small Mid Cap (TMSL)
Starbucks Corporation (SBUX)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Pimco Etf Tr Shtrm Mun Bd Act (SMMU)
JPMorgan Chase & Co. (JPM)

View all positions for Sittner & Nelson

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Invesco
Arrowstreet Capital, Limited Partnership
Bank of America Corporation
Robeco Investment Management
Morgan Stanley
William Blair Investment Management
Geode Capital Management
Snyder Capital Management
Dimensional Fund Advisors
D. E. Shaw & Co

View all funds holding Halozyme Therapeutics